Skip to main content
. 2007 Dec 4;98(1):71–76. doi: 10.1038/sj.bjc.6604121

Table 4. Available biological data on 20 patients.

NF-kB activation
  Yes (4) No (16)  
 PR 0 10 P<0.05
 SD 5 P<0.05
 PD 4 1 P<0.05
       
EGFR overexpression
  Yes (11) No (9)  
 PR 6 4 P=NS
 SD 1 4 P=NS
 PD 4 1 P=NS
       
EGFR amplification
  Yes (3) No (17)  
 PR 1 9  
 SD 2 3  
 PD 5  

EGFR=epidermal growth factor receptor; NF-kB=nuclear factor-kB; NS=non-significant; PR=partial response; PD=progressive disease; SD=stable disease.